Compare Ascendis Pharma A/S (ASND) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs First Citizens BancShares Inc — how do they compare? Ascendis Pharma A/S trades at $245.47 (market cap $16.71B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is the larger of the two by market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | FCNCA | |
|---|---|---|
Market Cap | $16.71B | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $277.18 | $2.27K |
52-Week Low | $189.74 | $1.64K |
Enterprise Value | $17.08B | — |
Dividend Yield | — | 0.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
